Skip to main content
Home
❮ Back to EMA website

Main navigation

  • Annual Report Homepage
  • Foreword
  • Introduction
  • CHAPTER 1
  • Key achievements in 2022
  • Evaluation and monitoring of medicines: highlights
  • European medicines regulatory network's response to public health emergencies
  • EMA's extended mandate
  • Implementing the Veterinary Medicinal Products Regulation
  • Improving the environment for clinical research in the EU
  • Data analytics and methods
  • Key events in 2022
  • CHAPTER 2
  • Data Highlights
  • Human medicines
  • Veterinary medicines
  • Inspections and compliance
  • Network, stakeholders, administration and communication

Key events in 2022

Share:
Previous
Data analytics and methods
Next
Chapter 2: Human medicines
  • Past annual reports
  • Ask a question
  • Help us with your feedback
  • Back to EMA corporate website
  • RSS
  • Twitter
  • YouTube
  • LinkedIn

Title: European Medicines Agency annual report 2022

PrintISBN 978-92-9155-074-6ISSN 1725-3225doi:10.2809/175386TC-AA-23-001-EN-C
PDFISBN 978-92-9155-073-9ISSN 2467-2106doi:10.2809/08948TC-AA-23-001-EN-N
HTMLISBN 978-92-9155-075-3ISSN 2467-2106doi:10.2809/57707TC-AA-23-001-EN-Q
© 2023 European Medicines Agency